Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression

Hideaki Kaneto1, Gang Xu, Nobuharu Fujii

  • 1Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.

Insights

Oxidative stress impairs pancreatic beta-cell function by activating the JNK pathway, which reduces insulin gene expression. Suppressing this JNK pathway protects beta-cells and improves insulin secretion in diabetic models.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Molecular Biology

Background:

  • Oxidative stress is implicated in pancreatic beta-cell dysfunction during diabetes.
  • The specific signaling pathways mediating oxidative stress-induced beta-cell dysfunction are not fully understood.

Purpose of the Study:

  • To investigate the role of specific signaling pathways, particularly JNK, in oxidative stress-induced beta-cell dysfunction.
  • To determine if targeting the JNK pathway can protect beta-cells from oxidative damage and preserve insulin secretion.

Main Methods:

  • Rat islets were subjected to oxidative stress.
  • Adenovirus-mediated gene expression was used to manipulate JNK, p38 MAPK, and protein kinase C activity.
  • Inhibition and overexpression strategies were employed to assess pathway involvement.
  • Functional assays measured insulin gene expression and secretion.
  • A mouse model of diabetes (streptozotocin-induced) was used for in vivo transplantation studies.

Main Results:

  • Oxidative stress activated JNK, p38 MAPK, and protein kinase C in rat islets, preceding reduced insulin gene expression.
  • Overexpression of dominant-negative JNK (DN-JNK) protected insulin gene expression and secretion from oxidative stress.
  • Wild-type JNK overexpression suppressed insulin gene expression and secretion.
  • DN-JNK preserved the DNA binding activity of the transcription factor PDX-1 to the insulin promoter under oxidative stress.
  • Transplantation of DN-JNK-expressing islets into diabetic mice preserved insulin gene expression and ameliorated hyperglycemia.

Conclusions:

  • JNK pathway activation is a key mediator of reduced insulin gene expression by oxidative stress in pancreatic beta-cells.
  • Suppression of the JNK pathway offers a protective strategy against oxidative stress-induced beta-cell dysfunction.
  • Targeting the JNK pathway may be a therapeutic approach for managing diabetes.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...